Open AccessCM227/CM9-LA: evidence supporting ipilimumab-based immunotherapy in the first-line treatment of metastatic NSCLC
Author(s) -
Emily F. Collier,
Sarah B. Goldberg
Publication year - 2020
Publication title -
precision cancer medicine
Language(s) - English
Resource type - Journals
ISSN - 2617-2216
DOI - 10.21037/pcm-2020-02
Subject(s) - ipilimumab , medicine , immunotherapy , metastatic melanoma , oncology , first line , cancer